KOKenneth J. O'Byrne
Kenneth J. O'Byrne
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenneth J. O'Byrne has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Steven George Gray
Thoracic Oncology Research Group, Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland
24 shared publications K. Gately
11 shared publicationsM.P. Barr
10 shared publicationsS. Cuffe
10 shared publicationsS. Heavey
10 shared publicationsK.A. Gately
9 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in Lung Cancer
- Vol. 103, S4
7: Normal bronchial epithelial cells exhibit altered cellular behaviour when exposed to lung cancer cells in a co-culture system
- 1 January 2017
- Published by Elsevier in Lung Cancer
- Vol. 103, S4
7: Normal bronchial epithelial cells exhibit altered cellular behaviour when exposed to lung cancer cells in a co-culture system
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S21-S22
54: An evaluation of lysine demethylase family members in malignant pleural mesothelioma
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S21-S22
54: An evaluation of lysine demethylase family members in malignant pleural mesothelioma
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S2
5: Mechanisms of resistance to dual PI3K–mTOR inhibition in NSCLC cell lines
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S2
5: Mechanisms of resistance to dual PI3K–mTOR inhibition in NSCLC cell lines
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S2
4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S2
4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S1
2: Platinum-induced DNA damage and repair mechanisms in non-small cell lung cancer
- 1 January 2015
- Published by Elsevier in Lung Cancer
- Vol. 87, S1
2: Platinum-induced DNA damage and repair mechanisms in non-small cell lung cancer
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S4
10 Development and characterization of a panel of NSCLC cell lines resistant to PI3K/mTOR inhibitor GDC-0980
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S4
10 Development and characterization of a panel of NSCLC cell lines resistant to PI3K/mTOR inhibitor GDC-0980
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S4
9 Co-targeting the PI3K and MEK pathways in NSCLC: an in vitro evaluation and mutation prevalence in an Irish patient cohort
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S4
9 Co-targeting the PI3K and MEK pathways in NSCLC: an in vitro evaluation and mutation prevalence in an Irish patient cohort
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S2-S3
5 MicroRNA profiling and characterisation of putative cancer stem cells in cisplatin resistant NSCLC
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S2-S3
5 MicroRNA profiling and characterisation of putative cancer stem cells in cisplatin resistant NSCLC
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S1
1 Targeting NF-κB regulated pathways to overcome cisplatin resistance in non-small cell lung cancer
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S1
1 Targeting NF-κB regulated pathways to overcome cisplatin resistance in non-small cell lung cancer
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S30
80 Epigenetic readers and writers as therapeutic targets in malignant pleural mesothelioma
- 1 January 2014
- Published by Elsevier in Lung Cancer
- Vol. 83, S30
80 Epigenetic readers and writers as therapeutic targets in malignant pleural mesothelioma